Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Pittrow

Showing results (131-140 of 150) with videos related to

Pageof 15
Sort By:
Circulation|October 2, 2013
Anticoagulation and survival in pulmonary arterial hypertension: results from the Comparative, Prospective Registry of Newly Initiated Therapies for Pulmonary Hypertension (COMPERA)Karen M Olsson, Marion Delcroix, H Ardeschir Ghofrani, et al.
International Journal of Cardiology|November 21, 2012
Elderly patients diagnosed with idiopathic pulmonary arterial hypertension: results from the COMPERA registryMarius M Hoeper, Doerte Huscher, H Ardeschir Ghofrani, et al.
ERJ Open Research|January 21, 2026
Risk stratification as a guide to goal-oriented management of patients with fibrotic interstitial lung disease: a registry-based analysisJürgen Behr, Antje Prasse, Hubert Wirtz, et al.
Journal of Clinical Medicine|June 26, 2025
Beyond the Scale: The Hidden Burden of Underweight and Cachexia in Adults with Congenital Heart Defects and Heart Failure-Results from the Pathfinder CHD-RegistryAnn-Sophie Kaemmerer-Suleiman, Sebastian Freilinger, Annika Freiberger, et al.
Geriatrics (Basel, Switzerland)|November 24, 2025
Dual Disease Burden: Growing Older with Congenital Heart Disease and Hereditary Metabolic and Connective Tissue Disorders-Data from the PATHFINDER-CHD Registry on Heart FailureAnn-Sophie Kaemmerer-Suleiman, Frank Harig, Annika Freiberger, et al.
Respiratory Medicine|February 4, 2021
Riociguat treatment in patients with chronic thromboembolic pulmonary hypertension: Final safety data from the EXPERT registryHossein-Ardeschir Ghofrani, Miguel-Angel Gomez Sanchez, Marc Humbert, et al.
The European Respiratory Journal|October 22, 2021
Temporal trends in pulmonary arterial hypertension: results from the COMPERA registryMarius M Hoeper, Christine Pausch, Ekkehard Grünig, et al.
Respiratory Medicine|January 10, 2021
Riociguat treatment in patients with pulmonary arterial hypertension: Final safety data from the EXPERT registryMarius M Hoeper, Miguel-Angel Gomez Sanchez, Marc Humbert, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|April 17, 2022
Prognostic value of improvement endpoints in pulmonary arterial hypertension trials: A COMPERA analysisMarius M Hoeper, Christine Pausch, Karen M Olsson, et al.
The European Respiratory Journal|November 5, 2021
COMPERA 2.0: a refined four-stratum risk assessment model for pulmonary arterial hypertensionMarius M Hoeper, Christine Pausch, Karen M Olsson, et al.
Pageof 15

Showing results (131-140 of 150) with videos related to

Sort By:
Pageof 15
Circulation|October 2, 2013
Anticoagulation and survival in pulmonary arterial hypertension: results from the Comparative, Prospective Registry of Newly Initiated Therapies for Pulmonary Hypertension (COMPERA)Karen M Olsson, Marion Delcroix, H Ardeschir Ghofrani, et al.
International Journal of Cardiology|November 21, 2012
Elderly patients diagnosed with idiopathic pulmonary arterial hypertension: results from the COMPERA registryMarius M Hoeper, Doerte Huscher, H Ardeschir Ghofrani, et al.
ERJ Open Research|January 21, 2026
Risk stratification as a guide to goal-oriented management of patients with fibrotic interstitial lung disease: a registry-based analysisJürgen Behr, Antje Prasse, Hubert Wirtz, et al.
Journal of Clinical Medicine|June 26, 2025
Beyond the Scale: The Hidden Burden of Underweight and Cachexia in Adults with Congenital Heart Defects and Heart Failure-Results from the Pathfinder CHD-RegistryAnn-Sophie Kaemmerer-Suleiman, Sebastian Freilinger, Annika Freiberger, et al.
Geriatrics (Basel, Switzerland)|November 24, 2025
Dual Disease Burden: Growing Older with Congenital Heart Disease and Hereditary Metabolic and Connective Tissue Disorders-Data from the PATHFINDER-CHD Registry on Heart FailureAnn-Sophie Kaemmerer-Suleiman, Frank Harig, Annika Freiberger, et al.
Respiratory Medicine|February 4, 2021
Riociguat treatment in patients with chronic thromboembolic pulmonary hypertension: Final safety data from the EXPERT registryHossein-Ardeschir Ghofrani, Miguel-Angel Gomez Sanchez, Marc Humbert, et al.
The European Respiratory Journal|October 22, 2021
Temporal trends in pulmonary arterial hypertension: results from the COMPERA registryMarius M Hoeper, Christine Pausch, Ekkehard Grünig, et al.
Respiratory Medicine|January 10, 2021
Riociguat treatment in patients with pulmonary arterial hypertension: Final safety data from the EXPERT registryMarius M Hoeper, Miguel-Angel Gomez Sanchez, Marc Humbert, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|April 17, 2022
Prognostic value of improvement endpoints in pulmonary arterial hypertension trials: A COMPERA analysisMarius M Hoeper, Christine Pausch, Karen M Olsson, et al.
The European Respiratory Journal|November 5, 2021
COMPERA 2.0: a refined four-stratum risk assessment model for pulmonary arterial hypertensionMarius M Hoeper, Christine Pausch, Karen M Olsson, et al.
Pageof 15